dihexa clinical trials status EllieMD Unlocking the Potential of Dihexa
Description
Peptide-Oligo Conjugates Our peptide-oligonucleotide conjugate (POC) services seamlessly integrates our peptide and oligonucleotide platforms
Peptides may hold promise, but smart, supervised strategies will always deliver the most sustainable results
For at-home use, most GHK-Cu products, like serums and scalp treatments, contain concentrations between 2% and 4%
Until a more thorough understanding is achieved through rigorous clinical trials and research, any application of FOXO4-DRI must be navigated with utmost caution and under strict medical oversight
